ENDRA Life Sciences Inc. — Form D
ENDRA Life Sciences Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-24. The offering totals $14.4M, of which $14.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-10-24
- Form: D
- Accession: 0001681682-25-000004
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $14.4M
- Amount sold: $14.4M
- Minimum investment: $200K
- Investors: 6
- Date of first sale: 2025-10-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-562053
Issuer
- Name: ENDRA Life Sciences Inc.
- CIK: 0001681682
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3600 GREEN COURT, ANN ARBOR, MI, 48105
- Phone: 734-335-0468
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Louis J Basenese | Director | Tulsa, OK |
| Anthony J DiGiandomenico | Director | Ann Arbor, MI |
| Michael J Harsh | Director | Ann Arbor, MI |
| Alexander Tokman | Director | Ann Arbor, MI |
| Richard Jacroux | Executive Officer | Seattle, WA |
| Michael Thornton | Executive Officer | Ann Arbor, MI |
| Alexander Tokman | Executive Officer | Ann Arbor, MI |
| Alexander S Tokman | Director | Ann Arbor, MI |
| Michael S Harsh | Director | Ann Arbor, MI |
| Anthony R DiGiandomenico | Director | Ann Arbor, MI |
| Sanjiv S Gambhir | Director | Ann Arbor, MI |
| Michael R Thornton | Executive Officer | Ann Arbor, MI |
| Francois R Michelon | Director | Ann Arbor, MI |
| Francois R Michelon | Executive Officer | Ann Arbor, MI |
| Alexander Y Tokman | Director | Ann Arbor, MI |
| David R Wells | Executive Officer | Los Angeles, CA |
Other filings by this issuer (3)
More